Home | About | Journals | Submit | Contact Us | Français |

**|**PLoS Comput Biol**|**v.9(12); 2013 December**|**PMC3861043

Formats

Article sections

- Abstract
- Author Summary
- Introduction
- Results
- Discussion
- Materials and Methods
- Supporting Information
- References

Authors

Related links

PLoS Comput Biol. 2013 December; 9(12): e1003388.

Published online 2013 December 12. doi: 10.1371/journal.pcbi.1003388

PMCID: PMC3861043

Richard R. Stein,^{#}^{1,}^{*} Vanni Bucci,^{#}^{1,}^{*}^{¤} Nora C. Toussaint,^{2} Charlie G. Buffie,^{2} Gunnar Rätsch,^{1} Eric G. Pamer,^{2} Chris Sander,^{1} and João B. Xavier^{1,}^{*}

Christian von Mering, Editor^{}

University of Zurich and Swiss Institute of Bioinformatics, Switzerland

The authors have declared that no competing interests exist.

Conceived and designed the experiments: RRS VB CS JBX. Performed the experiments: RRS VB. Analyzed the data: RRS VB NCT. Contributed reagents/materials/analysis tools: CGB EGP. Wrote the paper: RRS VB NCT JBX. Provided key theoretical support for algorithm design: GR.

Received 2013 July 10; Accepted 2013 October 27.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been cited by other articles in PMC.

The intestinal microbiota is a microbial ecosystem of crucial importance to human health. Understanding how the microbiota confers resistance against enteric pathogens and how antibiotics disrupt that resistance is key to the prevention and cure of intestinal infections. We present a novel method to infer microbial community ecology directly from time-resolved metagenomics. This method extends generalized Lotka–Volterra dynamics to account for external perturbations. Data from recent experiments on antibiotic-mediated *Clostridium difficile* infection is analyzed to quantify microbial interactions, commensal-pathogen interactions, and the effect of the antibiotic on the community. Stability analysis reveals that the microbiota is intrinsically stable, explaining how antibiotic perturbations and *C. difficile* inoculation can produce catastrophic shifts that persist even after removal of the perturbations. Importantly, the analysis suggests a subnetwork of bacterial groups implicated in protection against *C. difficile*. Due to its generality, our method can be applied to any high-resolution ecological time-series data to infer community structure and response to external stimuli.

Recent advances in DNA sequencing and metagenomics are opening a window into the human microbiome revealing novel associations between certain microbial consortia and disease. However, most of these studies are cross-sectional and lack a mechanistic understanding of this ecosystem's structure and its response to external perturbations, therefore not allowing accurate temporal predictions. In this article, we develop a method to analyze temporal community data accounting also for time-dependent external perturbations. In particular, this method combines the classical Lotka–Volterra model of population dynamics with regression techniques to obtain mechanistically descriptive coefficients which can be further used to construct predictive models of ecosystem dynamics. Using then data from a mouse experiment under antibiotic perturbations, we are able to predict and recover the microbiota temporal dynamics and study the concept of alternative stable states and antibiotic-induced transitions. As a result, our method reveals a group of commensal microbes that potentially protect against infection by the pathogen *Clostridium difficile* and proposes a possible mechanism how the antibiotic makes the host more susceptible to infection.

The intestinal microbiota has been receiving much attention lately. Recent studies, propelled by metagenomics and next-generation DNA sequencing technologies, establish novel connections between the intestinal microbial species composition and diseases [1]–[3]. An imbalance in bacterial composition has been linked to chronic diseases such as obesity [4], Crohn's disease [5] and type 2 diabetes [6]. Even drug-induced transient changes in the microbial community can increase the risk of developing diseases such as acute intestinal infections [7], or pulmonary viral infections [8] in mammalian hosts.

Although its importance has long been acknowledged [9]–[12] studies of the microbiota had been limited by the fact that most microbes are uncultivable in the lab. The recent developments in metagenomic high-throughput sequencing allow this by enabling the investigation of species composition directly without the need for culturing [13]. This has opened a new window into the microbial ecosystem residing in the intestinal tract. Our present view is that the intestinal microbiota is a relatively resilient ecosystem [14], with a composition that is quite stable over time [15], [16]. External perturbations, such as dramatic changes in diet [17] or antibiotic administration [18], can shift the composition. For example, broad-spectrum antibiotics can remove highly abundant species and allow less abundant, antibiotic-tolerant bacteria to dominate [7]. Antibiotic-induced losses of biodiversity increase the risk of bacterial infections [19], [20] and the effects can persist for several days after antibiotic treatment [18], [19], [21]. Perturbation-induced composition shifts are often observed in multispecies microbial ecosystems and may affect macroscopic overall functionality [22]. The loss of protective species can be resolved by reintroducing normally resident (or commensal) microbes. Faecal transplantation, i.e. the reestablishment of a patient's intestinal microbiota by introducing the microbiota of a healthy donor, is highly effective against *Clostridium difficile* induced colitis [23], [24]. Similarly, the reintroduction of anaerobic flora with high levels of *Barnesiella* sp. can clear intestines from highly abundant vancomycin-resistant *Enteroccocus* in mice [25].

In order to understand how commensal consortia confer resistance against pathogens it is crucial to identify the network of interactions between the species [26]. Interactions can be mediated by a direct secretion of substances such as bacteriocins [27], or ecological competition between the microbes [28], or even indirect interactions through immune system modulation [29]. Most quantitative studies of the intestinal microbiota so far focused on comparing the composition of different samples using quantitative indices and correspondence analyses [14] and cross-sectional statistical tests [1], [30]. Likewise, associations between microbial species are often obtained using correlation-based algorithms [26], [31]–[36], which results in undirected interaction networks. Singular value decomposition [28] or mixture model engines [37] allow for individuating stereotypical modes of response to external perturbations (i.e. grouping species positively or negatively affected by the stimulus) but they provide no information on the interactions themselves (Figure 1A).

We recently introduced an ecological model of microbiota dynamics that considers both species interaction networks and extrinsic perturbations such as antibiotics [28]. The model can explain how relatively simple ecological interactions such as competition for nutrients can lead to complex phenomena as, for example, multi-stability or antibiotic-mediated catastrophic shifts. Importantly, we concluded that quantitative knowledge of the microbial interactions could enable the prediction of microbiota dynamics. Predictive models can be of great therapeutic value by guiding antibiotic selection to reduce the risk of antibiotic-induced enteric disease [20]. However, no study to date has generated predictive models of ecological interactions and antibiotic perturbations.

Inspired by work on interaction inference in cheese-associated microbial communities [38] we extend the generalized Lotka–Volterra equations [39], [40] to infer microbiota ecology and predict its temporal dynamics under time-dependent external perturbations. A related approach based on linear ordinary differential equations has already been applied to gene-interaction networks [41]–[44]. Specifically, our method enables the quantification of (1) growth rates of microbial species, (2) species–species interactions, and (3) susceptibilities of microbial groups to time-variable external perturbations such as antibiotics. Moreover, we can use these parameters to numerically predict dynamics of the microbiota and to characterize its stability (Figure 1B). Using this method, we analyze data from a recent mouse study [19], which shows that the antibiotic clindamycin increases susceptibility to *Clostridium difficile* colonization. Our results suggest the existence of resilience and multistability in the intestinal microbiota and lead to a hypothesis on a subnetwork of microbial groups involved in the native resistance against pathogen colonization. This study demonstrates that data-derived models of microbiota dynamics can have significant analytic and predictive power. As such, inference and prediction algorithms could be used in combination with metagenomics to assist in the rational design of therapies such as antibiotic or probiotic therapies [12].

Extracting model parameters using a time-discrete Lotka–Volterra system has already been presented in the context microbial communities [38], [45], [46]. We extend this approach by introducing time-variable perturbations and applying Tikhonov regularization to solve the discretized Lotka–Volterra equations. Furthermore, we use the obtained parameters to predict dynamics and assess the system's stability.

In this spirit, we adopt the general deterministic approach of modeling time-dependent ecological dynamics using generalized Lotka–Volterra equations [39] with the addition of external perturbations. Formally, this model consists of autonomous, non-linear, coupled first-order ordinary differential equations,

(1)

Here is the concentration of a focal species , , at time , is its specific growth rate, is the effect of the interaction of species on species and is the susceptibility to the time-dependent perturbation (for instance, an antibiotic or diet).

Ecological time-series data, such as longitudinal metagenomic sequencing data [15], [47], provide the composition of a community at discrete time points. Temporally resolved metadata, such as the timing of antibiotic administration [20] or of changes in diet regimes [17], may also be available and provide information about processes that perturb the microbiota. In order to translate the time-discrete data to a time-continuous dynamical system we divide (1) by and discretize (see Materials and Methods),

(2)

The model parameters are determined by a linear system of equations, which is then solved using Tikhonov regularization [48] in order to ensure uniqueness and stability of the solution,

(3)

The values for the regularization parameters , , can for example be found in -fold cross-validation (we use ) as the minimizer of the mean-squared stepwise prediction error to set the optimal trade-off between data fit and robustness towards the introduction of unseen or missing data [49].

The inference method was first tested on *in silico* data by generating trajectories for a Lotka–Volterra model as defined in (1). We created multiple trajectories of ecological systems characterized by different population sizes, random growth rates, interaction values and susceptibility parameters while ensuring system stability [50], 51. The simulations were also subjected to random perturbations of variable duration and white noise was added to simulate measurement uncertainty (Figure S1). The test confirms that the minimum of the stepwise prediction error can be used as a suitable proxy for the minimization of the parameter inference errors (Figure S2). Given the inferred parameters we can now predict the temporal dynamics by solving (1). We applied this approach to *in silico* data. The results are presented in Figure S3.

In a recent study, Buffie et al. described experiments on the effect of the antibiotic clindamycin on the intestinal colonization with the spore-forming pathogen *C. difficile*
[19]. The experiments were performed in a mouse model and high-throughput DNA sequencing was used to measure the relative abundance of bacterial species in cecum and ileum. The experiment consisted of three distinct populations of mice. The first population received spores of *C. difficile*, and was used to determine the susceptibility of the native microbiota to invasion by the pathogen. The second population received a single dose of clindamycin to assess the effect of the antibiotic alone. Finally, the third population received a single dose of clindamycin and, on the following day, was inoculated with *C. difficile* spores. The untreated mice challenged with *C. difficile* (population #1) did not develop infection and maintained a stable microbiota throughout the entire experiment. The single dose of antibiotic (population #2) resulted in a dramatic reduction in the microbiota biodiversity, with more than 90% of the initial species dropping below detection. The effects of this perturbation were long lasting, and biodiversity did not return to pre-treatment levels even 28 days after the clindamycin dose. Finally, mice that received *C. difficile* following the treatment with clindamycin (population #3) were colonized by the pathogen, with 40% of those mice dying due to *C. difficile* induced colitis.

The experiment was performed in three replicates: for each population three mouse colonies were uniformly treated, but separately housed. Each time point represents a mouse from each colony which was sacrificed to determine the intestinal microbiota composition. Mice from the same colony are biological replicates which justifies the interpretation of these compositions as one time line representing one co-housed mouse population [19].

We used the cecal content data to infer microbial interactions, growth rates and susceptibilities to clindamycin (see Materials and Methods). Our mechanistically-based model presupposes absolute abundances. Therefore, we converted the normalized DNA sequence abundances obtained by metagenomics by multiplying with the number of universal 16S rRNA per gram of cecal content (measured using qPCR) multiplied by the sample density,
[52] (the actual density value has little importance for the inference of the interactions given the model scaling invariance, see Materials and Methods). For consistency with the previous study [19] we integrated only the ten most abundant genera including the pathogen *C. difficile*, together accounting for the vast majority (approx. 90%) of the total sequences obtained from 16S rRNA high-throughput DNA sequencing (Figure S4). The remaining lower abundance microbes were grouped into a category called “Other” (see Materials and Methods). This choice resulted in less than 30% of undetected entries in the data matrix. The choice of a higher number of independently treated genera, e.g. 15, could result in more than 50% of missing values in the data matrix (Figure S5).

Consistent with the underlying biological assumptions, the specific growth rates obtained from our inference method (Figure 2A) are all positive, and concordant with values measured *in vitro* using representative species of human colonic microbiota (0.55–1.78 per day [53] compared to 0.2–0.9 from Figure 2A). The diagonal elements of the obtained interaction matrix (Figure 2B) are negative. This is again consistent with the underlying biology, since it means that each of these species would eventually reach carrying capacity even in the absence of other species.

*Coprobacillus* is found to be the genus with strongest interactions by value in the ecological network. Specifically, it appears to primarily inhibit all the other microbes, including *C. difficile*, with the exception of *Akkermansia* and *Blautia* which also show inhibitory effect on *C. difficile*. The strongest inhibitory effect is on *Enterococcus* which together with the group of unclassified Mollicutes is inferred to positively interact with the pathogen *C. difficile*. This positive association is consistent with previous reports [54], [55]. Intriguingly, our method also suggests *Barnesiella* to mildly inhibit *Enterococcus*, which agrees with previous findings in mice and humans [25]. Susceptibilities to clindamycin (Figure 2C) propose that the antibiotic inhibits all of the genera, except for *Enterococcus* and the group of undefined Enterobacteriaceae. *C. difficile* itself is mildly repressed by the antibiotic.

Next, we investigated the implications of the inferred model parameters for microbiota dynamics. First, we tested the model's performance in predicting microbiota trajectories. To do so, we inferred the growth, interaction and susceptibility parameters on of the available data, leaving of the trajectories to test the model prediction. Subsequently, we solved eq. (1) numerically using the inferred parameters, initial compositions and the metadata of antibiotic and/or *C. difficile* inoculation (see Materials and Methods for further details). In Figure 3, we compare the observed dynamics of the second replicates with the dynamics inferred from the first and third replicate. Figure S6 shows the full comparison for all the three replicates. The simulated trajectories show a good agreement with the experimental data for all the three populations with respect to order of magnitude and qualitative behavior. There are, however, discrepancies especially in Figure 3B. Here, the experimental data shows a community take-over of *Akkermansia* and *Blautia* three days after clindamycin treatment. Our method predicts the same behavior but with several days delay (see Discussion for possible explications and model limitations). The rank correlation between data and prediction is of 62% along time (Figure 3D).

We then investigated the long-term stability of the system. We calculated the steady-state composition of the microbiota, , as a solution of eq. (1) for vanishing the time-derivatives in the absence of any perturbation. Consequently, there are steady states where is the number of microbial groups in the system. Of these, one state corresponds to the trivial case of total extinction (), one state corresponds to the case of total coexistence (, for invertible), and states correspond to the permutations of existence or extinction for every other species [56]. A priori, we have no knowledge about which one of these states the system will attain. This depends on the initial composition, presence and duration of the external perturbations. Therefore, we determine the steady state by simulating long-term dynamics to obtain information on species extinction and coexistence. Once this information is obtained, we can analytically evaluate the steady state of the system and its qualitative behavior by determining the spectrum of the corresponding Jacobian matrix evaluated in that state (see Materials and Methods). The principle of linearized stability states that if the real part of the largest eigenvalue of the Jacobian is negative then the composition represents a stable microbiota (an asymptotically stable state). Otherwise, it is unstable [57]. For instance, the total extinction state, , is unstable if any of the growth rates is positive, which is true for our data (Figure 2A). However, the dynamics of high-dimensional Lotka–Volterra systems allow for a large variety of different qualitative behaviors such as limit cycles, chaos or attractors [39].

We applied this analysis to our system and identified one unique steady state for each independent replicate (Figure 4A). The replicate corresponding to untreated mice challenged with *C. difficile* (population #1) is characterized by high abundance of clindamycin-sensitive bacteria such as *Barnesiella*, undefined Lachnospiraceae and unclassified Lachnospiraceae. The steady state corresponding to clindamycin application (population #2) is characterized by a take-over by *Blautia*, unclassified Enterobacteriaceae and unclassified Mollicutes. Finally, for the case corresponding to *C. difficile* after clindamycin (population #3), the steady state predicts severe *C. difficile* colonization in addition to the genera emerging in population #2. Interestingly, these steady states agree in order of magnitude, community profiles and composition with the last experimentally measured data point of Figure 3A–C. However, in the observed trajectories the composition still changes between the last two observed data points. This could be due to the fact that the microbiota is not yet stabilized (i.e. still in transient dynamics) or due to the effect of fluctuations [15]. Although this cannot be discerned from a simple observation of the data, assuming that our model captures the actual microbiota ecology our analysis suggests that the microbiota of the perturbed microbial communities did not recover their original composition within 28 days from treatment cessation. Rather, the microbiota stays in distinct, perturbation-history dependent equilibria. The intact microbiota is, by antibiotic administration, driven towards a composition which is more susceptible to *C. difficile* colonization. By subsequent introduction of the pathogen, the community is dragged into an alternative stable composition including the otherwise repelled *C. difficile*; this may be an example of “niche opportunity” [58], [59]. Interestingly, when considering the landscape of all possible steady states of the inferred Lotka–Volterra model, unstable steady states, i.e. those referring to critical compositions which drive communities with similar compositions to a collapse or catastrophic shift [60], are significantly more often observed than stable ones. Given the inferred parameters, we find that of the steady states which the system is able to attain from a composition of *L* initially present genera, about 98% are found to be unstable (Figure 4B). Nonetheless, our model predicts the existence of multiple stable compositions in each of the three experimental arms. Our results, therefore, may indicate the existence of alternative stable compositions of the intestinal microbiota; switches between these states are induced by perturbation with clindamycin or *C. difficile* inoculation. This concept is reminiscent of ecological stability and resilience discussed by Connell and Sousa [61].

The inspection of the model inferred from mouse experiments [19] could suggest a possible ecological mechanism for *C. difficile* colonization (Figure 5A). In the intact microbiota, our method proposes that *Coprobacillus* interacts positively with the genera of *Akkermansia* and *Blautia*. Additionally, *Coprobacillus* inhibits *Enterococcus*, which, when increasing in abundance, enhances *C. difficile* establishment. Without clindamycin, the three genera *Coprobacillus*, *Akkermansia* and *Blautia*, maintain intestinal stability and confer resistance against *C. difficile* colonization (Figure 5B). However, when clindamycin is administered, *Coprobacillus*, *Akkermansia* and *Blautia*, are inhibited while *Enterococcus* is promoted. As the three protective groups decrease in abundance, our results suggest that *Enterococcus* increases in abundance and may facilitate colonization by *C. difficile*. We discuss the validity of this mechanism in the Discussion section.

We presented a general method for the inference and prediction of multispecies ecological community dynamics under perturbations. Although this method was primarily developed having in mind the intestinal microbiota, the same method may be potentially applied to time-resolved data from any ecological systems, such as bioreactors [62], marine [63] or soil ecosystems [64].

Our method quantifies growth rates, community interactions and susceptibilities to external perturbations in a single inference. The modeling approach is based on the generalized Lotka–Volterra model (eq. (1)), a system of non-linear ordinary differential equations, whose governing parameters can be stably determined by a regularized regression on the discretized version of the model (eq. (2)). Microbiota metagenomics data often have a high number of microbial species which is much larger than the number of available time points. This presents a challenge to inference. We solved this problem in two steps. The first step was to group the bacterial sequences at the genus level of phylogenic classification and consider only the ten most abundant microbial genera including the pathogen *C. difficile* and merge all remainders to “Others”. The second step was to apply Tikhonov regularization, a procedure that provides a unique and stable solution and, in combination with cross-validation, reduces the risk of overfitting noisy data. Our inference method was tested using *in silico* data (Figure S1) and evaluated by its ability to recover left-out data using a cross-validation approach (Figures S2, S3).

The application of inference methods to temporal metagenomic data shows great promise. Still, the development of accurate, predictive models, for example for clinical application, will require further developments and the next few years are sure to see major improvements in this area. For example, the method used here to group microbial sequences may be expanded by adding functional information in addition to taxonomic information. Future methods will benefit from deeper sequencing of the metagenome [65] to inform new ways to define functional microbial groups. Such analyses can shed new light, for example, on the mechanisms by which the abundance of certain species seem to correlate with susceptibility to colonization by closely related pathogenic bacteria [66]. Regarding antibiotic effects, even though we are not yet able to measure the effective concentrations of the antibiotic in the intestine in a high-throughput manner, more accurate information on the pharmacokinetics *in vivo* will greatly enhance the applicability of this method to clinical settings. Likewise, experimental advancements with animal models will also be crucial. The experiments analyzed here consisted of a single dose of clindamycin of by intraperitoneal injection [19]. Comparing antibiotic perturbed mice with intact mice in this case is similar to comparing a thriving forest with one that has burnt to the ground. The same antibiotic administered in gradual dosages, or the use of other antibiotics, will surely produce distinct effects and would allow for analyzing the communities with distinct compositions. Also, engineered artificial microbiota with defined numbers of bacteria in germ-free mice could be a valuable tool to test the resilience of communities with increasing complexity. Longitudinal data collected from such experimental models can give valuable new insight into the mechanisms of protection against *C. difficile*.

Other differences between data and simulation results may stem from approximating the infinitesimal by time-discrete dynamics and the fact that the Lotka–Volterra model incorporates only pairwise, second-order interactions (eq. (1)). This could be relaxed in the future by extending the model to third or higher-order interactions once more data becomes available. Furthermore, due to the requirements of the Lotka–Volterra framework our method cannot be applied directly to read count data without additional information on the total number of bacteria per volume unit. If this information is not available it needs to be estimated which can be a source of deviations between measured and predicted results. Nevertheless and even though we cannot claim that the inferred interactions are revealing real causative relationships among microbes, we believe that our results go beyond the explanatory power of widely-used correlations and other methods used. A major advantage of this method is its foundation on a mechanistic framework. This allows for the determination of directional interactions as well as the simulation of microbial dynamics with considerable agreement with the actual data.

Based on our inference results, we also hypothesized on a mechanism of *C. difficile* colonization. However, making a substantiated statement on this mechanism would require further analysis across different host systems and under various antibiotic perturbations. Moreover, due to the limited phylogenetic resolution of the 16S rRNA sequencing, our approach would assign the effects of possibly few, interaction-mediating strains to the whole genus. Nevertheless, the analysis presented here suggests possible experiments focusing on the role of *Enterococcus*, *Coprobacillus*, *Blautia* and *Akkermansia* in mediating *C. difficile* colonization. This could be investigated, for example, in mice with engineered microbial consortia. Specifically, the microbiota of these mice could be manipulated to lack the genus of *Enterococcus* or to contain after antibiotic treatment representative strains of genera such as *Coprobacillus*, *Blautia* and *Akkermansia* which are predicted to have protective effect. Non-colonization and clearance of *C. difficile* in this system after clindamycin application would then support our hypothesized infection mechanism.

There is an urgent need to understand how the commensal intestinal microbial community resists invasion by pathogenic species. Mathematical modeling and inference can help shed new light on this problem by disentangling the contribution of each factor at play. The combination of increasingly accurate and affordable sequencing methods with solidly grounded mathematical theory can help advance our understanding of the relationship between the human host and its microbial inhabitants.

A general approach for a deterministic model of time-dependent ecological dynamics is given by the following system of autonomous coupled first-order ordinary differential equations, in which each time course represents the time-variation in abundance, , of an ecological unit in a certain environment,

(4)

with unknown parameters, for . A requirement of ecological models for closed systems is that a unit that once goes extinct cannot return. Thus, for unit which is extinct at time , we require and at any time independent of any variation of the remaining , . In the framework of (4), this necessitates , for and for such that, if we restrict to only pairwise interactions, we obtain for each unit ,

(5)

where and for . This system of equations is also known as the Lotka–Volterra model [39]. The denotes the unlimited growth rate of unit in absence of any competition. The interaction term characterizes the effect of unit on . In particular, stands for activation and for repression. (No interaction is accordingly indicated by ). In this form, the model, which is governed by the absolute abundances of units and their physical, order-dependent interactions, also captures non-linear dynamics such as Monod-type/Michaelis–Menten kinetics in a first-order approximation. In addition to growth and interactions we introduce the effect of the application of external time-dependent stimuli, , on each ecological unit such that the full model writes,

(6)

where represents an external, time-variable stimulus of a perturbation whose relative susceptibility for each unit is represented by .

In the framework of metagenomic data, one faces large magnitudes of total numbers of bacteria. A common approach to identify scale-dependencies of the system and to circumvent numerical problems associated with this is to use non-dimensional variables which allow to treat the model relative to changes on typical system scales [67]. For this purpose, we introduce the following representation of the dynamical variables,

(7)

where the dimensionless forms are denoted with asterisks and the barred variables denote the typical scales of the variables. For the measurements of the intestinal microbiota used in our analysis, we find typical scales for abundance and time of and . Equation (1) then reads in dimensionless form as,

(8)

We choose the scale for the perturbation signal such that it is scaled to 1, i.e. . Thus, we obtain the rescaled growth rates, interaction parameters and susceptibilities as, , and and recover the original equation (1) by dropping the asterisks. Given this choice, the (rescaled) parameters of growth and susceptibility are found to be scale-invariant of changes in the typical abundance , in contrast to the interaction parameter .

Input variable is one longitudinal data-set in time points with abundances of taxonomic units (in the following analysis, genera), , and time-dependent perturbations represented by their signal . The parameters of interest are the growth, interaction and susceptibility parameters, , and .

In order to use the time-discrete data in the infinitesimal framework of the Lotka–Volterra system, we rewrite eq. (1) for ,

(9)

using for . For given values at discrete time points , the time derivative in (9) can be approximated by the forward difference quotient,

(10)

for and using . Note, there is no limitation to equally-spaced time steps. Accordingly, the discretization of the full equation (1) is then given by,

(11)

for successive time points . Note, the data points assigned to the last time, and , have to be removed from each trajectory. We regroup (2) in linear equation system employing the whole time-series information. For this purpose, we adopt a matrix notation for the unknown model parameters, the interaction matrix , the susceptibility matrix and the growth rate vector . Moreover, we tabulate the time-series information on the species' abundances and perturbations in and the corresponding difference quotients in , which yields for (2),

(12)

where

(13)

Note, equation set (12) is invariant to simultaneous flips of the columns of on the left and of the data matrix on the right hand side, i.e. the column order can be changed as long as it is done on both sides. This allows us to infer global parameters of interaction, growth and susceptibility, , and on multiple data sets by concatenating several time-series trajectories. In practice, equation (12) is analogously valid when the data matrices *F* and *Y* are filled with *S* independent trajectories each consisting of data points, , at time points for and .

Equations of type (12) are commonly solved by regularized linear regression with a suitable regularizer. This approach in combination with a suitable model evaluation reduces the risk of overfitting by finding the optimal trade-off between model complexity and predictability on unseen data [68]. For our problem, we use a Tikhonov regularization (also known as -regularization or ridge regression) with its standard formulation as minimization problem (3) with positive penalty terms . This biases the solution towards smallness of the parameters and relative to the square of the -norm . The -dependent solution is then given by,

(14)

(15)

with the diagonal matrix with entries for , and for . Since is positive-semidefinite, is sufficient to guarantee that is invertible and thus (15) has a unique solution.

To this point, can be chosen to select the set of , and which predicts best on unseen data. A standard approach to address this is to apply -fold cross-validation in which the data is randomly partitioned into equally sized subsets: of these are used to infer the parameters using (15) for several combinations of . The remaining, unseen subset is used to estimate the corresponding prediction errors, . This is repeated for all possible partitions into possible training sets and one test set. To reduce random fluctuations, several rounds using different random partitionings are performed. Based on the results of this procedure, we choose as the penalty parameter with the minimal averaged prediction error on unseen data. The final model is determined by applying to the complete data set. It is representative of the system's parameters and has been selected for best predictive performance on unseen data. In simulations on artificial data, we find that this procedure with and ten runs of cross-validation recovers successfully the model parameters (which are known in the case of *in silico* data), see Figure S2.

The long-term behavior of trajectories in Lotka–Volterra systems is determined by the model's steady states (also referred to as equilibrium or fixed points). The Lotka–Volterra equations are non-linear and therefore allow for the existence of multiple steady states. Any trajectory in a certain environment of an asymptotically stable steady state solution tends to approach this state in time. Principally, this also applies to solutions under perturbations and allows the system to stay in or recover its original configuration. This behavior can be compared to some extent with the notion of resilience, i.e. the ability of a system to keep or recover its original state after perturbations, in the context of ecological systems.

The global enables us to predict the dynamics of unseen systems given only the initial composition and the time-dependent signal of perturbations and/or introduced taxonomic units. For this purpose, we use the obtained parameters determined on the full data set except for the to be predicted trajectory (or all trajectories of a certain group). Given the obtained parameters, we subsequently solve eq. (2) numerically using the initial values of the to be predicted trajectories.

In particular, the steady states of system (1), , are determined by for with . Their qualitative behavior is characterized by the spectrum of the corresponding Jacobian matrix evaluated in that state,

(16)

The principle of linearized stability states that, if the real part of all eigenvalues of the Jacobian is negative, then is asymptotically stable. Otherwise, it is unstable [57].

The operational taxonomic units counts per sample and relative phylogenetic profile as presented in [19] were used as input data for our analysis. As described in the Results section, we considered the ten most abundant genera (including the pathogen *C. difficile*) and a group “Other” containing the remaining lower abundance genera. The particular grouping was used to reduce sparsity in the data matrix and to avoid spurious, presumably noise-driven contributions. The choice of using the genus level for phylogenetic resolution was dictated by the fact that 1) it is consistent with the original published paper [19] and 2) it represents the most specific phylogenetic level for which we have classification data. In our grouping, we denote a microbial genus “undefined” (abbreviated with “und.”) when the phylogenetic classification was non-ambiguous up to a certain phylogenetic level.

In contrast to Buffie et al. [19] in which the data of the three replicates are presented by their average, we use the individual nine time courses from the cecum (three from each colony) and concatenate their compositions spanning 86 time points into the data matrices and . In case of non-detection of an otherwise present genus, we assign a uniformly distributed random value between zero and the detection limit of the corresponding sample. Whenever a genus is completely absent from all considered samples in a particular inference, its corresponding row in the data matrix of above is set to zero. The perturbation signal for clindamycin is modeled by a unit pulse of length day centered on the time of antibiotic administration.

Subsequently, the inference was performed as described above with , i.e. in every round of cross-validation, six of the nine time courses were used as training and the remaining three as test set. Ten rounds of cross-validation yielded the minimizing regularization parameter . The result for using all the data of nine time courses is presented in Figure 2.

In the next step, we predicted the behavior of known trajectories only using their initial compositions and clindamycin application and/or *C. difficile* inoculation and compared it to the measured values. We used from above to infer , and on six out of the nine trajectories, two from each population. These parameters were used to solve eq. (2) numerically for the remaining three trajectories only providing initial compositions and perturbation profiles and/or *C. difficile* inoculation. Figure 3 shows the predicted trajectories of the second replicate of each of the three populations using parameters inferred on the remaining six.

Moreover, the same parameters were used to assess the stability of the three steady states by linear stability analysis (see above). In Figure 4, we compared these to the final composition of the corresponding measured time courses.

Inference and prediction algorithms were implemented in MATLAB R2012b (Mathworks Inc., Natick, MA). Numerical integration of the ordinary differential equation systems were performed using the native function ODE15s. Simulations were run in the cluster facility at cBio@MSKCC.

Microsoft Excel file reporting data (processed taxa densities as well as antibiotic profiles), optimal regularization parameters and inferred model parameters.

(XLSX)

Click here for additional data file.^{(32K, xlsx)}

Typical *in silico* trajectory of studied species with superimposed white noise and under application of three random perturbations as used in the *in silico* validation of our method.

(EPS)

Click here for additional data file.^{(1.4M, eps)}

Comparison of stepwise prediction error vs. error on inferred parameters for variation of the regularization parameters. It can be seen that the minimum in stepwise prediction error and error in parameters approximately coincide.

(EPS)

Click here for additional data file.^{(1.1M, eps)}

Generated *in silico* input data for inference (blue symbols) and superimposed trajectories obtained by inference and re-run of the ordinary differential equation system (black lines).

(EPS)

Click here for additional data file.^{(9.1M, eps)}

Histogram of time-averaged abundances of the ten most abundant genera (including *C. difficile*) and “Other”. The grouping covers 90% of all detected individual genera.

(EPS)

Click here for additional data file.^{(728K, eps)}

Coverage of the remainder group “Other” (blue) considering distinct most abundant genera compared to the fraction of entries below detection limit in the data matrix (red).

(EPS)

Click here for additional data file.^{(817K, eps)}

Comparison of measured data and predicted time courses. The column number of each time line determines its replicate number (1 to 3) and the row number points to which population it belongs (#1 to #3). In particular, of the nine trajectories, A, D and G correspond to the population inoculated only with *C. difficile* spores, B, E and H to the ones only treated with clindamycin and C, F and I to the cases in which the mice were treated with clindamycin and subsequently inoculated with *C. difficile* spores.

(EPS)

Click here for additional data file.^{(2.2M, eps)}

We would like to acknowledge Chris Widmer, Dr. Petra Louis and Prof. Harry Flint for insightful discussion.

This work was supported by a US National Cancer Institute grant through the Integrative Cancer Biology Program (CA148967; JBX and CS), by the Office Of The Director, National Institutes of Health under Award Number DP2OD008440 to JBX and by a seed grant from the Lucille Castori Center for Microbes, Inflammation and Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

1. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, et al. (2011) Enterotypes of the human gut microbiome. Nature 473: 174–180 [PMC free article] [PubMed]

2. Dave M, Higgins PD, Middha S, Rioux K (2012) The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 160: 246–257 [PubMed]

3. Blaser M, Bork P, Fraser C, Knight R, Wang J (2013) The microbiome explored: recent insights and future challenges. Nature Rev Microbiol 11: 213–217 [PubMed]

4. Flint H (2011) Obesity and the gut microbiota. J Clin Gastroenterol 45: S128. [PubMed]

5. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, et al. (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13: R79. [PMC free article] [PubMed]

6. Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5: e9085. [PMC free article] [PubMed]

7. Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, et al. (2010) Vancomycin-resistant enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120: 4332. [PMC free article] [PubMed]

8. Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, et al. (2011) Microbiota regulates immune defense against respiratory tract inuenza a virus infection. Proc Natl Acad Sci 108: 5354–5359 [PubMed]

9. Freter R (1962) In vivo and in vitro antagonism of intestinal bacteria against shigella exneri: II. the inhibitory mechanism. J Infect Dis 110: 38–46 [PubMed]

10. Bohnhoff M, Miller CP, Martin WR (1964) Resistance of the mouse's intestinal tract to experimental salmonella infection I. factors which interfere with the initiation of infection by oral inoculation. J Exp Med 120: 805–816 [PMC free article] [PubMed]

11. Cho I, Blaser MJ (2012) The human microbiome: at the interface of health and disease. Nature Rev Genet 13: 260–270 [PMC free article] [PubMed]

12. Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148: 1258–1270 [PubMed]

13. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. (2005) Diversity of the human intestinal microbial ora. Science 308: 1635–1638 [PMC free article] [PubMed]

14. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489: 220–230 [PMC free article] [PubMed]

15. Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, Gonzalez A, et al. (2011) Moving pictures of the human microbiome. Genome Biol 12: R50. [PMC free article] [PubMed]

16. Relman DA (2012) The human microbiome: ecosystem resilience and health. Nutr Rev 70: S2–S9 [PMC free article] [PubMed]

17. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, et al. (2010) Dominant and dietresponsive groups of bacteria within the human colonic microbiota. ISME J 5: 220–230 [PMC free article] [PubMed]

18. Dethlefsen L, Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci 108: 4554–4561 [PubMed]

19. Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, et al. (2012) Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to clostridium difficile-induced colitis. Infect Immun 80: 62–73 [PMC free article] [PubMed]

20. Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, et al. (2012) Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55: 905–914 [PMC free article] [PubMed]

21. Jernberg C, Löfmark S, Edlund C, Jansson J (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1: 56–66 [PubMed]

22. Allison SD, Martiny JB (2008) Resistance, resilience, and redundancy in microbial communities. Proc Natl Acad Sci 105: 11512–11519 [PubMed]

23. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, et al. (2011) Treating clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9: 1044–1049 [PMC free article] [PubMed]

24. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, et al. (2013) Duodenal infusion of donor feces for recurrent clostridium difficile. New Engl J Med 368: 407–415 [PubMed]

25. Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint N, et al. (2013) Intestinal microbiota containing barnesiella cures vancomycin-resistant enterococcus faecium colonization. Infect Immun 81: 965–973 [PMC free article] [PubMed]

26. Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, et al. (2012) Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol 8: e1002606. [PMC free article] [PubMed]

27. Bucci V, Nadell CD, Xavier JB (2011) The evolution of bacteriocin production in bacterial biofilms. Amer Nat 178: E162–E173 [PubMed]

28. Bucci V, Bradde S, Biroli G, Xavier JB (2012) Social interaction, noise and antibiotic-mediated switches in the intestinal microbiota. PLoS Comput Biol 8: e1002497. [PMC free article] [PubMed]

29. Khosravi A, Mazmanian SK (2013) Disruption of the gut microbiome as a risk factor for microbial infections. Curr Opin Microbiol 16: 221–227 [PubMed]

30. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, et al. (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12: R60. [PMC free article] [PubMed]

31. Reshef DN, Reshef YA, Finucane HK, Grossman SR, McVean G, et al. (2011) Detecting novel associations in large data sets. Science 334: 1518–1524 [PMC free article] [PubMed]

32. Friedman J, Alm EJ (2012) Inferring correlation networks from genomic survey data. PLoS Comput Biol 8: e1002687. [PMC free article] [PubMed]

33. Segata N, Boernigen D, Tickle TL, Morgan XC, Garrett WS, et al. (2013) Computational metaomics for microbial community studies. Mol Sys Biol 9: 666 [PubMed]

34. Ruan Q, Dutta D, Schwalbach MS, Steele JA, Fuhrman JA, et al. (2006) Local similarity analysis reveals unique associations among marine bacterioplankton species and environmental factors. Bioinformatics 22: 2532–2538 [PubMed]

35. Xia L, Steele J, Cram J, Cardon Z, Simmons S, et al. (2011) Extended local similarity analysis (elsa) of microbial community and other time series data with replicates. BMC Syst Biol 5: S15. [PMC free article] [PubMed]

36. Xia LC, Ai D, Cram J, Fuhrman JA, Sun F (2013) Efficient statistical significance approximation for local similarity analysis of high-throughput time series data. Bioinformatics 29: 230–237 [PubMed]

37. Gerber GK, Onderdonk AB, Bry L (2012) Inferring dynamic signatures of microbes in complex host ecosystems. PLoS Comput Biol 8: e1002624. [PMC free article] [PubMed]

38. Mounier J, Monnet C, Vallaeys T, Arditi R, Sarthou AS, et al. (2008) Microbial interactions within a cheese microbial community. Appl Environ Microbiol 74: 172–181 [PMC free article] [PubMed]

39. Hofbauer J, Sigmund K (1998) Evolutionary games and population dynamics. Cambridge University Press.

40. May RM (2001) Stability and complexity in model ecosystems, volume 6. Princeton University Press.

41. Yeung MKS, Tegnér J, Collins JJ (2002) Reverse engineering gene networks using singular value decomposition and robust regression. Proc Natl Acad Sci 99: 6163–6168 [PubMed]

42. Gardner TS, Di Bernardo D, Lorenz D, Collins JJ (2003) Inferring genetic networks and identifying compound mode of action via expression profiling. Science 301: 102–105 [PubMed]

43. Bonneau R, Reiss DJ, Shannon P, Facciotti M, Hood L, et al. (2006) The inferelator: an algorithm for learning parsimonious regulatory networks from systems-biology data sets de novo. Genome Biol 7: R36. [PMC free article] [PubMed]

44. Bansal M, Della Gatta G, Di Bernardo D (2006) Inference of gene regulatory networks and compound mode of action from time course gene expression profiles. Bioinformatics 22: 815–822 [PubMed]

45. White JR (2010) Novel Methods for Metagenomic Analysis. Ph.D. thesis, University of Maryland.

46. Faust K, Raes J (2012) Microbial interactions: from networks to models. Nature Rev Microbiol 10: 538–550 [PubMed]

47. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, et al. (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci 108: 4680–4687 [PubMed]

48. Tikhonov A, Arsenin VY (1977) Solution of Ill-posed Problems. VH Winston & Sons.

49. Aster RC, Borchers B, Thurber CH (2012) Parameter estimation and inverse problems. Academic Press.

50. Zeeman ML (1995) Extinction in competitive Lotka–Volterra systems. Proc Amer Math Soc 123: 87–96

51. Kim JG (1996) Coexistence in competitive Lotka–Volterra systems. Comm Kor Math Soc 11: 147–151

52. Lupton JR, Ferrell RG (1986) Using density rather than mass to express the concentration of gastrointestinal tract constituents. J Nutr 116: 164–168 [PubMed]

53. Šimŭnek J, Brandysová V, Koppová I, Šimŭnek J Jr (2012) The antimicrobial action of chitosan, low molar mass chitosan, and chitooligosaccharides on human colonic bacteria. Folia Microbiol 57: 341–345 [PubMed]

54. Samore MH, Carmeli Y, Eliopoulos GM (2002) Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant enterococcus. Emerg Infect Dis 8: 802–807 [PMC free article] [PubMed]

55. Donskey CJ, Ray AJ, Hoyen CK, Fuldauer PD, Aron DC, et al. (2003) Colonization and infection with multiple nosocomial pathogens among patients colonized with vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol 24: 242–245 [PubMed]

56. Vano J, Wildenberg J, Anderson M, Noel J, Sprott J (2006) Chaos in low-dimensional Lotka–Volterra models of competition. Nonlinearity 19: 2391

57. Amann H (1990) Ordinary differential equations: an introduction to nonlinear analysis, volume 13. de Gruyter.

58. Shea K, Chesson P (2002) Community ecology theory as a framework for biological invasions. Trends Ecol Evol 17: 170–176

59. Shade A, Peter H, Allison SD, Baho DL, Berga M, et al. (2012) Fundamentals of microbial community resistance and resilience. FMICB 3: 417. [PMC free article] [PubMed]

60. Dai L, Vorselen D, Korolev KS, Gore J (2012) Generic indicators for loss of resilience before a tipping point leading to population collapse. Science 336: 1175–1177 [PubMed]

61. Connell JH, Sousa WP (1983) On the evidence needed to judge ecological stability or persistence. Amer Nat 121: 789–824

62. Werner JJ, Knights D, Garcia ML, Scalfone NB, Smith S, et al. (2011) Bacterial community structures are unique and resilient in full-scale bioenergy systems. Proc Natl Acad Sci 108: 4158–4163 [PubMed]

63. Caporaso JG, Paszkiewicz K, Field D, Knight R, Gilbert JA (2011) The western english channel contains a persistent microbial seed bank. ISME J 6: 1089–1093 [PMC free article] [PubMed]

64. Banning NC, Gleeson DB, Grigg AH, Grant CD, Andersen GL, et al. (2011) Soil microbial community successional patterns during forest ecosystem restoration. Appl Environ Microbiol 77: 6158–6164 [PMC free article] [PubMed]

65. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, et al. (2007) The human microbiome project. Nature 449: 804–810 [PMC free article] [PubMed]

66. Stecher B, Chaffron S, Käppeli R, Hapfelmeier S, Freedrich S, et al. (2010) Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog 6: e1000711. [PMC free article] [PubMed]

67. Barenblatt GI (1996) Scaling, self-similarity, and intermediate asymptotics: dimensional analysis and intermediate asymptotics, volume 14. Cambridge University Press.

68. Bishop CM (2006) Pattern recognition and machine learning. Springer New York.

Articles from PLoS Computational Biology are provided here courtesy of **Public Library of Science**

PubMed Central Canada is a service of the Canadian Institutes of Health Research (CIHR) working in partnership with the National Research Council's national science library in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine(NCBI/NLM). It includes content provided to the PubMed Central International archive by participating publishers. |